6.3. Non-maleficence

Non-maleficence – “Do no harm.”

Non-maleficence is a fundamental principle in bioethics that stresses the importance of not causing harm to others. It means that when making decisions in the context of biotechnology and medicine, one should always consider the potential for harm and strive to minimize any negative effects that might occur as a result of one's actions. This principle underlines the responsibility of researchers, practitioners, and policymakers to prioritize the safety and well-being of individuals and communities when implementing biotechnological advancements.

Imagine a doctor who faces a decision about whether to prescribe a new medication that has shown promise for treating a disease. If the medication has not been tested extensively and there are reports of severe side effects, the doctor must consider non-maleficence; that is, they must ask themselves whether prescribing this medication might do more harm than good to their patients.

This principle emphasizes safety in biotechnological applications.

The principle of non-maleficence is crucial in biotechnology due to the inherent risks associated with genetic modifications, medical treatments, and other biotechnological interventions. These applications can have far-reaching and sometimes unpredictable consequences. By emphasizing safety, biotechnologists and healthcare providers are reminded to conduct thorough risk assessments, monitor outcomes, and implement regulatory measures designed to protect individuals and the environment from potential harm. This principle ensures that technological progress does not come at the expense of safety and ethical responsibility.

Consider the introduction of a genetically modified crop designed to resist pests. Farmers and biotechnologists must evaluate whether this crop could inadvertently harm beneficial insect populations or lead to new forms of resistance in pests. For example, if a new strain of pest develops resistance due to the modified crop, this could lead to increased pesticide use, potentially harming the environment. Non-maleficence compels researchers to consider these potential outcomes before proceeding.

There are often dilemmas in balancing benefits and risks.

In practice, applying the principle of non-maleficence can present significant challenges. One major dilemma is the balance between the benefits of a biotechnological innovation and its potential risks. For example, while a new genetic therapy may help alleviate suffering from a genetic disorder, the long-term effects on patients and their descendants may be unknown. Bioethicists and scientists must engage in careful deliberation, often using ethical frameworks and decision-making models to assess the magnitude of potential harm against the proposed benefits. This continuous balancing act ensures that the quest for progress does not lead to harmful consequences.

Think of the development of a vaccine. Vaccines can prevent disease and save millions of lives, but they can also come with risks of side effects. When scientists develop a new vaccine, they need to weigh the potential benefits of preventing outbreaks against the risk of adverse reactions in a small percentage of recipients. This involves rigorous testing and monitoring to ensure that the benefits indeed outweigh the risks, embodying the principle of non-maleficence.

--